People · Operator
Named in public records as an officer, director or promoter · active 2006–2024 · Healthtech, Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Monteris Medical US, Inc. | — | Healthtech | Series B | $82.5M | $168.0M | 2014 |
| Monteris Medical Inc | — | Biotechnology | Seed | $9.0M | $163.1M | 2013 |
| Nephrx Corp | — | Biotechnology | Series A | $6.2M | $224.8M | 2007 |
| NanoMed Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $3.0M | $116.0M | 2006 |
| Anchor Balloon, Inc. | — | Biotechnology | Seed | $3.0M | $8.7M | 2024 |
Patrick Morand at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Morand on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gregory Barrett | 2 | 4 |
| John Schellhorn | 2 | 4 |
| James Richardson | 2 | 4 |
| Gary Bantle | 2 | 2 |
| Robert K Davidson | 2 | 2 |
| Daniel Cole | 2 | 2 |
| Kevin McGarry | 2 | 2 |
| Kirk Nielsen | 1 | 13 |
| Donald Parfet | 1 | 5 |
| Douglas Morton | 1 | 3 |
| Matthew Strobeck | 1 | 3 |
| James Reinstein | 1 | 3 |
| Joseph Biller | 1 | 3 |
| Richard Emmitt | 1 | 3 |
| Joe Biller | 1 | 3 |
| Martin Emerson | 1 | 2 |
| James Erickson | 1 | 2 |
| Vishal Gupta | 1 | 2 |
| JAMES KOZIARZ | 1 | 2 |
| THOMAS COX | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.